Eltek Q2 revenue drops 8% to $11.5 million
Eltek (NASDAQ:ELTK) reported Q2 2026 revenue of $11.5 million, down 8% year over year, while net loss reached $2.7 million.
Eltek (NASDAQ:ELTK) reported Q2 2026 revenue of $11.5 million, down 8% year over year, while net loss reached $2.7 million.
Klarna Group (NYSE:KLAR) reported Q2 2026 revenue of $1.042 billion, up 27% year over year, as GMV increased 18% to $36.6 billion.
BlossomHill Therapeutics (NASDAQ:BLSM) received FDA Fast Track designation for BH-30643 in adults with advanced or metastatic EGFR C797S-positive non-small cell lung cancer.
Flotek Industries (NYSE:FTK) reaffirmed 2026 revenue guidance of $340–$350 million as work on its Puerto Rico power project was halted.
Immatics (NASDAQ:IMTX) reported Q2 2026 collaboration revenue of $10.4 million, up from $5.4 million, while its net loss narrowed to $71.2 million.
Amylyx Pharmaceuticals (NASDAQ:AMLX) said avexitide met the Phase 3 LUCIDITY primary endpoint with a 55% reduction in Level 2 and Level 3 hypoglycemic events versus placebo.
Canadian Solar (NASDAQ:CSIQ) said the remaining U.S. patent proceeding brought by Maxeon Solar was resolved in its favor after the federal infringement lawsuit was dismissed with prejudice.
Einride (NASDAQ:ENRD) plans to deploy 500 Tesla (NASDAQ:TSLA) Semi trucks across North America through its Saga AI fleet intelligence platform.
Einride (NASDAQ:ENRD) reported H1 2026 constant-currency revenue of SEK273 million ($27 million), up 26% year over year as customer volumes and fleet deployments increased.
Elauwit Connection (NASDAQ:ELWT) reported Q2 2026 revenue of $2.9 million, down 46% year over year, while net loss widened to $3.1 million.
GET YOUR GRAFA EDGE NOW
Sign up free to unlock this feature
We'll switch on a 30-day Edge trial as a welcome gift